Regeneron Pharmaceuticals (REGN)
Operating Expenses
$9.21B
TTM · Period ending: · USD
REGN Operating Expenses
Latest reported$9.21Bperiod ending
Latest reported$9.21Bperiod ending
REGN Operating Expenses ($2.00M → $9.21B)
Annual operating expenses
High-resolution chart · PNG
REGN operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 8,664,300,000 | |
| 8,240,800,000 | |
| 6,524,100,000 | |
| 5,082,100,000 | |
| 4,401,200,000 | |
| 3,564,700,000 | |
| 3,372,400,000 | |
| 3,594,100,000 | |
| 3,250,108,000 | |
| 3,125,247,000 | |
| 2,384,194,000 | |
| 1,723,422,000 | |
| 1,147,658,000 | |
| 796,569,000 | |
| 615,685,000 | |
| 534,765,999 | |
| 437,438,000 | |
| 316,077,000 | |
| 227,991,000 | |
| 148,016,000 | |
| 163,340,000 | |
| 17,062,000 | |
| 150,809,000 | |
| 137,458,000 | |
| 101,147,000 | |
| 68,986,000 | |
| 54,700,000 | |
| 45,800,000 | |
| 38,000,000 | |
| 40,300,000 | |
| 35,000,000 | |
| 52,400,000 | |
| 49,400,000 | |
| 29,800,000 | |
| 4,100,000 | |
| 2,000,000 |